Peter Nählstedt
Chief Executive Officer at SENZAGEN AB
Profile
Currently, Peter Nählstedt is Chairman at Doublegood AB, Chairman of Super Synbiotics AB and President & Chief Executive Officer of SenzaGen AB.
He is also on the board of Bio-Works Technologies AB.
In the past he held the position of Chief Executive Officer & IR Contact at Probi AB.
He received a graduate degree and an undergraduate degree from the University of Lund.
Peter Nählstedt active positions
Companies | Position | Start |
---|---|---|
BIO-WORKS TECHNOLOGIES AB | Director/Board Member | 2020-05-14 |
SENZAGEN AB | Chief Executive Officer | 2021-08-18 |
Doublegood AB
Doublegood AB Food: Major DiversifiedConsumer Non-Durables Doublegood AB produces health food. | Chairman | - |
Super Synbiotics AB
Super Synbiotics AB Food RetailRetail Trade Super Synbiotics AB is a Swedish company that offers synbiotic dietary supplements for the stomach. The private company's products are based on over 15 years of clinical studies and consist of probiotics and prebiotics. The company has conducted 20 years of research to develop their synbiotic products. | Chairman | - |
Former positions of Peter Nählstedt
Companies | Position | End |
---|---|---|
PROBI AB | Chief Executive Officer | 2018-03-13 |
Training of Peter Nählstedt
University of Lund | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
PROBI AB | Health Technology |
SENZAGEN AB | Health Technology |
BIO-WORKS TECHNOLOGIES AB | Health Technology |
Private companies | 2 |
---|---|
Doublegood AB
Doublegood AB Food: Major DiversifiedConsumer Non-Durables Doublegood AB produces health food. | Consumer Non-Durables |
Super Synbiotics AB
Super Synbiotics AB Food RetailRetail Trade Super Synbiotics AB is a Swedish company that offers synbiotic dietary supplements for the stomach. The private company's products are based on over 15 years of clinical studies and consist of probiotics and prebiotics. The company has conducted 20 years of research to develop their synbiotic products. | Retail Trade |